Physician profile
Justin Michael Broyles
NPI 1295034940
$47,884.41
in general payments reported to CMS, 2019-2025
9 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2021: $461 · 2022: $240 · 2023: $1,834 · 2024: $16K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $4,466 · Food and Beverage: $1,921 · Honoraria: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,046.79 |
| Travel and Lodging | $4,465.95 |
| Food and Beverage | $1,920.62 |
| Honoraria | $1,137.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43,661.35 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $1,585.40 | 2019-2021 | |
| Davol INC. | $1,156.23 | 2025 | Phasix Mesh |
| Mentor Worldwide LLC | $722.92 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Sientra, INC. | $328.76 | 2021 | |
| Elutia, INC. | $248.49 | 2025 | Ecm Patch,Pouch |
| Axogen | $113.18 | 2025 | |
| Tei Biosciences INC | $41.65 | 2019 | |
| Tela Bio, INC. | $26.43 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Broyles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.